HESHAM MOHAMED to Disease-Free Survival
This is a "connection" page, showing publications HESHAM MOHAMED has written about Disease-Free Survival.
Connection Strength
0.169
-
Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma. Br J Cancer. 2018 07; 119(1):89-95.
Score: 0.033
-
Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma. Head Neck. 2017 07; 39(7):1412-1420.
Score: 0.030
-
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034. Am J Hematol. 2016 09; 91(9):869-74.
Score: 0.029
-
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity. Cancer. 2016 May 01; 122(9):1398-407.
Score: 0.028
-
Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study. Blood. 2014 Apr 10; 123(15):2317-24.
Score: 0.024
-
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). Blood. 2014 Jan 23; 123(4):494-500.
Score: 0.024